Baclofen for Smoking Cessation in a Non-Psychiatric Population

NCT01228994 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped The study was terminated because of difficulties recruiting subjects.

Conditions

Nicotine Dependence

Interventions

DRUG: Baclofen 30 mg/day
DRUG: placebo pill
DRUG: Baclofen 60 mg/day

Sponsor

Centre for Addiction and Mental Health

Collaborators

[object Object]